Ordeniza, Rafael F.

HRN: 21-73-27  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2022
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
08/07/2022
08/13/2022
IVT
400mg
Q8 X 7 Days
Amoebiasis
Waiting Final Action 
08/07/2022
CEFTRIAXONE 1G (VIAL)
08/07/2022
08/13/2022
IV DRIP
4g
Q24 H
Uti
Waiting Final Action 
08/07/2022
CEFUROXIME 1.5GM (VIAL)
08/07/2022
08/13/2022
IVT
750mg Ivt
Q8 X 7 Days
Uti
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: